as 03-28-2025 4:00pm EST
Founded: | 2010 | Country: | United States |
Employees: | N/A | City: | IRVINE |
Market Cap: | N/A | IPO Year: | N/A |
Target Price: | $19.43 | AVG Volume (30 days): | 2.5M |
Analyst Decision: | Buy | Number of Analysts: | 7 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 0.54 | EPS Growth: | 807.61 |
52 Week Low/High: | $13.31 - $20.03 | Next Earning Date: | 05-07-2025 |
Revenue: | $702,638,000 | Revenue Growth: | 9.00% |
Revenue Growth (this year): | 5.23% | Revenue Growth (next year): | 4.66% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Cusack Catherine | SBRA | Director | Feb 21 '25 | Buy | $16.18 | 2,500 | $40,315.00 | 59,083 |
SBRA Breaking Stock News: Dive into SBRA Ticker-Specific Updates for Smart Investing
Business Wire
3 days ago
Argus Research
5 days ago
Business Wire
7 days ago
MT Newswires
13 days ago
Barrons.com
25 days ago
Argus Research
a month ago
Argus Research
a month ago
GuruFocus.com
a month ago
The information presented on this page, "SBRA Sabra Health Care REIT Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.